SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-002974
Filing Date
2015-05-20
Accepted
2015-05-20 09:03:48
Documents
21
Period of Report
2015-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_052015.htm 8-K 21406
2 EXHIBIT 99.1 exh_991.htm EX-99.1 18005
3 exh991_01.jpg GRAPHIC 97774
4 exh991_02.jpg GRAPHIC 180399
5 exh991_03.jpg GRAPHIC 140061
6 exh991_04.jpg GRAPHIC 144300
7 exh991_05.jpg GRAPHIC 81265
8 exh991_06.jpg GRAPHIC 127297
9 exh991_07.jpg GRAPHIC 140181
10 exh991_08.jpg GRAPHIC 109965
11 exh991_09.jpg GRAPHIC 127353
12 exh991_10.jpg GRAPHIC 125431
13 exh991_11.jpg GRAPHIC 140031
14 exh991_12.jpg GRAPHIC 78366
15 exh991_13.jpg GRAPHIC 138904
16 exh991_14.jpg GRAPHIC 98319
17 exh991_15.jpg GRAPHIC 79094
18 exh991_16.jpg GRAPHIC 133025
19 exh991_17.jpg GRAPHIC 143503
20 exh991_18.jpg GRAPHIC 127431
21 exh991_19.jpg GRAPHIC 86752
  Complete submission text file 0001171843-15-002974.txt   3210902
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 15878347
SIC: 2834 Pharmaceutical Preparations